New Frontiers in Cancer Treatment: Mounjaro's Potential Beyond Weight Loss

Tirzepatide belongs to a class of drugs that mimic the effects of glucagon-like peptide-1 (GLP-1), a hormone naturally released in the body after eating. It also imitates glucose-dependent insulinotropic polypeptide (GIP), another hormone that impacts insulin secretion, fat storage, and appetite regulation. By engaging both pathways, tirzepatide appears to suppress hunger and improve metabolic health more effectively than older drugs like Ozempic or Wegovy, which target only the GLP-1 pathway.